Roundtable
Unifying Compute, Data, and AI for Multidisciplinary Analysis in Pharmaceutical Development
May 7 | 12:40-1:30pm ET
Breakthroughs in drug discovery and pharmaceutical innovation increasingly depend on the convergence of advanced computing and interdisciplinary efforts.
However, R&D teams face challenges in data management, integrating large and varied data sources often siloed across many teams. Cloud-enabled R&D platforms are emerging as essential tools to address these issues, facilitating multidisciplinary collaboration, regulatory compliance, and governance for AI-driven methods.
This presentation will explore how Cloud HPC and AI/ML accelerate drug discovery, enable simulation at scale, and facilitate the building of digital threads across the pharma lifecycle. We will discuss strategies for data governance to ensure traceability, reproducibility, and streamline workflows, ultimately driving efficiency and innovation in the age of digital R&D.
RSVP
Attendees must be registered for the the PD2M conference to attend the roundtable. If you are not registered and would like to attend, please visit this link.
Discussion Topics
- Multidisciplinary Collaboration in the Age of Digital R&D
- Accelerating Drug Discovery with AI/ML and Cloud HPC
- Cloud-Enabled R&D Transformation
- Data Governance for AI-Driven Scientific Workflows
- Simulation at Scale
- Building Digital Threads Across the Pharma Lifecycle
- Supply Chain Optimization for Manufacturing in Pharma
Related Simulation and Modeling applications:
- Molecular Dynamics (MD) Simulations and Molecular Docking
- Quantum Mechanics/Molecular Mechanics (QM/MM) Simulations
- Protein Structure Prediction
- Physiologically-based pharmacokinetics
- Free Energy Perturbation/Calculations
- Quantitative structure-property relationship
- Computational Fluid Dynamics
Meet your hosts
Rescale is the leading cloud-based platform for HPC+AI-enabled product innovation, serving chemical engineers in developing new drug formulations, optimizing manufacturing processes, and driving breakthroughs in genomics.
Rescale Powers Innovation
Accelerating Life Science Breakthroughs
Life Science researchers and scientists across disciplines such as pharmacology, genomics, and medical devices are applying high performance computing (HPC) in their R&D, taking advantages of new cloud infrastructures for their simulations and complexity of navigating discovery, production, and approval processes has pushed fixed HPC
infrastructure to its limits. Industry-leading companies that span pharmaceutical and biotechnology to academic and commercial testing laboratories, are looking for new ways to enhance their simulation capabilities by leveraging dynamic
cloud resources to boost agility, collaboration, and most importantly the safety and efficacy of new treatments.
Leveraging Rescale’s cloud platform and its advanced collaboration and data transfer and management tools, scientists can access the virtually unlimited resources required to perform advanced simulations.